LILRB1 polymorphisms influence posttransplant HCMV susceptibility and ligand interactions.
Yu K, Davidson CL, Wójtowicz A, Lisboa L, Wang T, Airo AM, Villard J, Buratto J, Sandalova T, Achour A, Humar A, Boggian K, Cusini A, van Delden C, Egli A, Manuel O, Mueller N, Bochud PY; Swiss Transplant Cohort Study; Burshtyn DN.
Yu K, et al. Among authors: sandalova t.
J Clin Invest. 2018 Apr 2;128(4):1523-1537. doi: 10.1172/JCI96174. Epub 2018 Mar 12.
J Clin Invest. 2018.
PMID: 29528338
Free PMC article.
Clinical Trial.